Kopran Stock Screener | Share Price & Fundamental Analysis
KOPRAN
Pharmaceuticals
Screen Kopran share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹147.74
▼
-4.34 (-2.85%)
Share Price BSE
₹148.00
▼
-4.20 (-2.76%)
Market Cap
₹726.39 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.45
EPS (TTM)
₹7.99
Dividend Yield
1.99%
Debt to Equity
0.24
52W High
₹213.28
52W Low
₹124.29
Operating Margin
10.00%
Profit Margin
5.68%
Revenue (TTM)
₹176.00
EBITDA
₹20.00
Net Income
₹10.00
Total Assets
₹844.00
Total Equity
₹518.00
Kopran Share Price History - Stock Screener Chart
Screen KOPRAN historical share price movements with interactive charts. Analyze price trends and patterns.
Kopran Company Profile - Fundamental Screener
Screen Kopran company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KOPRAN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE082A01010
Kopran Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen KOPRAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 844 | 743 | 650 | 611 | 439 | 371 | 352 | 316 | 298 | 264 |
| Current Assets | 510 | 454 | 399 | 415 | 277 | 223 | 208 | 194 | 180 | 154 |
| Fixed Assets | 208 | 182 | 165 | 151 | 112 | 111 | 113 | 104 | 105 | 101 |
| Liabilities | ||||||||||
| Total Liabilities | 844 | 743 | 650 | 611 | 439 | 371 | 352 | 316 | 298 | 264 |
| Current Liabilities | 37 | 34 | 34 | 33 | 34 | 42 | 49 | 35 | 37 | 33 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 518 | 491 | 439 | 426 | 245 | 190 | 169 | 145 | 125 | 109 |
| Share Capital | 48 | 48 | 48 | 48 | 43 | 43 | 43 | 43 | 43 | 52 |
| Reserves & Surplus | 470 | 443 | 391 | 378 | 202 | 146 | 125 | 102 | 81 | 57 |
Screen KOPRAN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 176 | 138 | 118 | 196 | 142 | 153 | 166 | 153 | 119 | 153 | 161 | 145 | 126 | 117 | 160 |
| Expenses | 155 | 121 | 123 | 164 | 121 | 137 | 146 | 137 | 111 | 130 | 135 | 117 | 113 | 107 | 146 |
| EBITDA | 20 | 17 | -5 | 31 | 21 | 16 | 20 | 16 | 9 | 23 | 26 | 28 | 14 | 11 | 15 |
| Operating Profit % | 10.00% | 10.00% | -4.00% | 12.00% | 13.00% | 10.00% | 12.00% | 8.00% | 5.00% | 15.00% | 15.00% | 18.00% | 10.00% | 9.00% | 8.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 14 | 10 | -12 | 25 | 15 | 10 | 14 | 11 | 4 | 18 | 21 | 24 | 10 | 6 | 9 |
| Tax | 4 | 2 | -2 | 7 | 4 | 2 | 4 | 3 | 1 | 5 | 5 | 7 | 2 | 1 | 2 |
| Net Profit | 10 | 7 | -10 | 19 | 11 | 7 | 10 | 8 | 3 | 14 | 16 | 18 | 8 | 5 | 7 |
| EPS | 2.01 | 1.54 | -2.06 | 3.86 | 2.30 | 1.53 | 2.16 | 1.67 | 0.58 | 2.86 | 3.28 | 3.68 | 1.58 | 0.97 | 1.44 |
Kopran Cash Flow Screener - Liquidity Fundamentals
Screen KOPRAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 42 | 43 | 34 | -34 | 60 | 31 | 25 | 26 | 16 | 29 |
| Investing Activities | -56 | -44 | -13 | -84 | -25 | -13 | -25 | -11 | -18 | -9 |
| Financing Activities | 26 | 1 | -20 | 123 | -35 | -18 | -1 | -15 | 2 | -19 |
| Net Cash Flow | 11 | 1 | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen KOPRAN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.42% | 44.42% | 44.42% | 44.49% | 44.49% | 44.49% | 44.46% | 44.30% |
| FII Holding | 1.12% | 0.76% | 0.60% | 0.84% | 0.68% | 1.32% | 0.86% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 1.20% | 0.14% | 0.22% | 0.00% | 0.14% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.36% | 42.83% | 44.65% | 37.98% | 39.69% | 40.74% | 41.35% | 39.05% |
| Other Holding | 13.10% | 11.99% | 10.33% | 15.49% | 15.01% | 13.23% | 13.32% | 16.52% |
| Shareholder Count | 58,652 | 60,194 | 62,222 | 50,850 | 51,492 | 57,154 | 60,560 | 41,567 |
Kopran Dividend Screener - Share Yield Analysis
Screen KOPRAN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹3.00 | 2.00% |
| 2024-March | ₹3.00 | 1.71% |
| 2023-March | ₹3.00 | 1.16% |
| 2022-March | ₹3.00 | 2.97% |
| 2021-March | ₹3.00 | 1.07% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Kopran Index Membership - Market Screener Classification
Screen KOPRAN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Kopran Market Events Screener - Corporate Actions
Screen KOPRAN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.00 /share | -10.35% | ||
| Dividend | ₹ 3.00 /share | 66.33% | ||
| Dividend | ₹ 3.00 /share | 18.17% | ||
| Annual General Meeting | NA | 26.71% | ||
| Annual General Meeting | NA | 2.79% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -4.13% |
| 2025-07-29 | 2025-07-29 | Quarterly Result Announcement | NA | -1.94% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 7.28% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -0.98% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 0.67% |
| 2022-08-04 | 2022-08-08 | Dividend | ₹ 3.00 /share | -10.27% |
| 2021-08-05 | 2021-08-09 | Dividend | ₹ 1.50 /share | 6.33% |
Kopran Competitors Screener - Peer Comparison
Screen KOPRAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,614 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 169,701 | 68.64 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 130,301 | 60.42 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 122,079 | 22.17 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 106,115 | 18.42 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 96,362 | 21.87 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 92,005 | 18.03 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 90,673 | 50.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,709 | 20.16 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 65,838 | 26.89 | 13,458 | 3.70% | 2,216 | 41.76 |
Kopran Company Announcements - News Screener
Screen KOPRAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-01 | Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-29 | Closure of Trading Window | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-30 | Board Meeting Intimation for Financial Result Q2 FY 2025-26 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-15 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-15 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-11 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-08 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-08-25 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | View |
| 2025-08-25 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | View |